CURE5 小时
First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...
Study reveal single-cell landscape of innate and acquired drug resistance in acute myeloid ...
In a recent study from the acute myeloid leukemia (AML) arm of the Tumor Profiler, published in Nature Communications, ...